16 November 2026 | Monday | News
Image Source: Public Domain
Bavarian Nordic A/S (OMX: BAVA) launches the second tranche of the share buy-back program announced on August 21, under which the Company intends to repurchase own shares for up to DKK 750 million. The second tranche will comprise buy-back of shares for up to DKK 250 million.
The purpose of the new share buy-back program is to adjust the capital structure, through subsequent cancellation of shares repurchased under this program, subject to any necessary additional corporate resolutions, as applicable.
The share buy-back program is initiated pursuant to the authorization granted at the annual general meeting on April 21, 2026, and in accordance with Regulation (EU) No. 596/2014 (as amended) of the European Parliament and of the Council on market abuse and Commission Delegated Regulation (EU) 2016/1052, which together constitute the Safe Harbour Regulation.
Bavarian Nordic has appointed Danske Bank as lead manager to execute the share buy-back in accordance with the terms of the program and with authorization to make trading decisions independently and without influence of Bavarian Nordic.
Terms of the program
Details of transactions under the program will be published weekly after commencement and at completion of the program.
Prior to the initiation of this program, Bavarian Nordic held 4,664,037 treasury shares, corresponding to 5.88% of the Company’s share capital.
© 2026 Biopharma Boardroom. All Rights Reserved.